CHinese Acute Tissue-Based Imaging Selection for Lysis In Stroke -Tenecteplase
Status:
Active, not recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
To select the best dosage of tenecteplase for acute ischemic stroke patients (onset time
4.5-24h) of large vessel occlusion using early combined CT/MR imaging outcomes
Phase:
Phase 2
Details
Lead Sponsor:
Huashan Hospital
Collaborators:
First People's Hospital of Shenyang Huai'an Second People's Hospital Ningbo No. 1 Hospital Pu'er City People's Hospital Shanghai 10th People's Hospital Shanghai 5th People's Hospital Shanghai 6th People's Hospital Shanghai East Hospital ShuGuang Hospital The First Affiliated Hospital of Shanxi Medical University The First Affiliated Hospital of Zhengzhou University The Second Affiliated Hospital of Chongqing Medical University Zhejiang Province People's Hospital